Importantly, the expression levels of ADAMTS9-AS2 were significantly decreased in the resistance group (namely, chemoresistant ccRCC cells) compared to the control group (Figure 5E, P<0.01), whereas the opposite results were obtained with the expression levels of miR-27a-3p (Figure 5F, P<0.05). This evidence concerns the gene ADAMTS9 and nonpapillary renal cell carcinoma.